Identification of the Genes Encoding Cancer Antigens: Implications for Cancer Immunotherapy

This publication has 100 references indexed in Scilit:

• Characterization of natural peptide ligands for HLA‐B*4402 and ‐B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA‐B44 heavy chain
  Tissue Antigens, 1994
• Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.
  The Journal of Experimental Medicine, 1994
• Can antitumor immune responses discriminate between self and nonself?
  Immunology Today, 1994
• Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
  Science, 1994
• Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: Analysis by cytokine secretion
  Cancer Immunology, Immunotherapy, 1993
• A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
  Science, 1991
• Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role
  Cell, 1991
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988
• A pigmentation‐associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum
  International Journal of Cancer, 1983
• Vitiligo in patients with metastatic melanoma: A good prognostic sign
  Journal of the American Academy of Dermatology, 1983